ABBV PEER ANALYSIS

AbbVie Inc — metric-by-metric comparison with peers and the industry median

ABBVAbbVie Inc

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

ABBVIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ABBV	SAN	BAYN	AZN	Ind. Median
P/E	124.19	8.66●	—	28.27	22.54
P/B	-68.35●	1.23	1.74	6.20	4.53
EV/EBITDA	30.46	9.57●	23.53	15.69	13.48
P/S	7.19	1.93	1.11●	4.86	3.14

Financial Health
Metric	ABBV	SAN	BAYN	AZN	Ind. Median
Current Ratio	0.80	1.01	1.06●	0.91	1.25
Debt/Equity	-1,101.9%●	27.5%	134.8%	71.7%	94.3%
NetDebt/EBITDA	3.75	1.33	9.19	1.29●	1.35

Profitability
Metric	ABBV	SAN	BAYN	AZN	Ind. Median
Net Margin	5.8%	22.3%●	-4.8%	17.2%	15.0%
ROE	—	14.1%	-7.0%	23.5%●	23.7%
ROA	2.7%	8.0%	-2.0%	9.4%●	8.0%
EBITDA Margin	26.9%	23.4%	7.7%	33.7%●	28.4%

Growth + Dividend
Metric	ABBV	SAN	BAYN	AZN	Ind. Median
Rev. Growth	9.5%	3.3%	-2.9%	9.9%●	3.3%
NI Growth	-13.3%	59.8%●	—	33.7%	32.9%
Div. Yield	2.7%●	0.0%	0.2%	0.2%	2.1%
Payout	324.8%	0.0%	-5.9%	47.3%	45.7%

Valuation
Metric	ABBV	JNJ	MRK	AMGN	LLY	GILD	Ind. Median
P/E	124.19	30.14	35.08	25.56	42.54	17.64●	22.54
P/B	-68.35●	7.81	6.83	21.69	34.46	6.91	4.53
EV/EBITDA	30.46	19.92	19.00	14.66	33.27	12.07●	13.48
P/S	7.19	6.58	4.78●	5.35	14.88	5.47	3.14

Financial Health
Metric	ABBV	JNJ	MRK	AMGN	LLY	GILD	Ind. Median
Current Ratio	0.80	1.03	1.30	1.26	1.50	1.97●	1.25
Debt/Equity	-1,101.9%●	67.7%	107.1%	623.8%	139.0%	94.3%	94.3%
NetDebt/EBITDA	3.75	0.98	2.31	2.71	1.14	0.85●	1.35

Profitability
Metric	ABBV	JNJ	MRK	AMGN	LLY	GILD	Ind. Median
Net Margin	5.8%	21.8%	13.6%	20.9%	35.0%●	31.0%	15.0%
ROE	—	26.4%	19.0%	101.3%	107.6%●	43.2%	23.7%
ROA	2.7%	10.7%	7.3%	8.6%	24.5%●	16.4%	8.0%
EBITDA Margin	26.9%	34.8%	28.6%	44.8%	46.3%	48.7%●	28.4%

Growth + Dividend
Metric	ABBV	JNJ	MRK	AMGN	LLY	GILD	Ind. Median
Rev. Growth	9.5%	7.9%	2.5%	9.1%	47.4%●	3.5%	3.3%
NI Growth	-13.3%	-3.5%	-48.7%	31.5%	127.6%●	54.5%	32.9%
Div. Yield	2.7%●	2.1%	2.6%	2.7%	0.5%	2.5%	2.1%
Payout	324.8%	59.5%	92.1%	66.7%	22.1%	43.8%	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ABBV

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.